Close Menu

NEW YORK – Akadeum Life Sciences announced on Thursday an initial close of its Series A financing, which will be used to "solve longstanding problems in sample preparation."

A spokesman for the Ann Arbor, Michigan-based firm said that it has raised about $4 million in the Series A round so far but declined to say how much it plans to raise in total "because we expect the round to be oversubscribed." In a statement, Akadeum added that it is pursuing additional financing during the first quarter of 2020 when the Series A round is anticipated to close.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.